SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-061106
Filing Date
2014-08-14
Accepted
2014-08-14 16:43:42
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14017_110q.htm 10-Q 1057078
2 EX-31.1 a14-14017_1ex31d1.htm EX-31.1 11198
3 EX-31.2 a14-14017_1ex31d2.htm EX-31.2 11107
4 EX-32.1 a14-14017_1ex32d1.htm EX-32.1 4217
5 EX-32.2 a14-14017_1ex32d2.htm EX-32.2 4218
  Complete submission text file 0001104659-14-061106.txt   7461580

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20140630.xml EX-101.INS 929151
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20140630.xsd EX-101.SCH 70086
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20140630_cal.xml EX-101.CAL 54006
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20140630_def.xml EX-101.DEF 297741
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20140630_lab.xml EX-101.LAB 1203176
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20140630_pre.xml EX-101.PRE 552922
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 141043706
SIC: 2834 Pharmaceutical Preparations